ID: ALA3645242

Max Phase: Preclinical

Molecular Formula: C32H41F3N6O2

Molecular Weight: 598.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(C(=O)N(C[C@@H]2CNC[C@@H]2F)[C@@H](c2nc(-c3cc(F)ccc3F)nn2Cc2ccccc2)C(C)(C)C)C[C@H](C)O1

Standard InChI:  InChI=1S/C32H41F3N6O2/c1-20-16-39(17-21(2)43-20)31(42)40(19-23-14-36-15-27(23)35)28(32(3,4)5)30-37-29(25-13-24(33)11-12-26(25)34)38-41(30)18-22-9-7-6-8-10-22/h6-13,20-21,23,27-28,36H,14-19H2,1-5H3/t20-,21+,23-,27-,28-/m0/s1

Standard InChI Key:  AWBVBYIKAUDSGH-KHNIKYAWSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 598.71Molecular Weight (Monoisotopic): 598.3243AlogP: 5.45#Rotatable Bonds: 7
Polar Surface Area: 75.52Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 5.70CX LogD: 3.65
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.39Np Likeness Score: -1.11

References

1.  (2013)  Triazole compounds as KSP inhibitors, 

Source

Source(1):